Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 6-[(1r)-1-hydroxyethyl]-4-methyl-3,7-dioxo-, (4-nitrophenyl)methyl Ester, (4r,5r,6s)-
2. 104873-15-6
3. Schembl2062622
4. P-nitrobenzyl (1r,5r,6s)-6-[1(r)-hydroxyethyl]-1-methyl-2-oxocarbapenam-3-carboxylate
5. (1r, 5r, 6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2- Oxocarbapenam-3-carboxylic Acid 4-nitrobenzyl Ester
6. (1r, 5r, 6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-carbapenam-3-carboxylic Acid 4-nitrobenzyl Ester
7. (1r, 5r, 6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxocarbapenam-3-carboxylic Acid 4-nitrobenzyl Ester
8. (4r,5beta)-3,7-dioxo-4alpha-methyl-6beta-[(r)-1-hydroxyethyl]-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4-nitrobenzyl Ester
9. 4-nitro-benzyl (1r,5r,6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate
10. 4-nitrobenzyl (1r, 5r, 6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate
11. 4-nitrobenzyl (1r, 5r, 6s)-6[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate
12. 4-nitrobenzyl (1r,5r,6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate
13. 4-nitrobenzyl (4r, 5r, 6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-3, 7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
14. 4-nitrobenzyl (4r,5r,6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]-heptane-2-carboxylate
15. 4-nitrobenzyl (4r,5r,6s)-6-[(1r)-1-hydroxyethyl]-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate
16. P-nitrobenzyl (1r,5r,6s)-6-[(1r)-1-hydroxyethyl]-1-methyl-2-oxo-1-carbapenam-3-carboxylate
Molecular Weight | 362.3 g/mol |
---|---|
Molecular Formula | C17H18N2O7 |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 362.11140092 g/mol |
Monoisotopic Mass | 362.11140092 g/mol |
Topological Polar Surface Area | 130 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 623 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Surecn2062622 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Surecn2062622, including repackagers and relabelers. The FDA regulates Surecn2062622 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Surecn2062622 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Surecn2062622 supplier is an individual or a company that provides Surecn2062622 active pharmaceutical ingredient (API) or Surecn2062622 finished formulations upon request. The Surecn2062622 suppliers may include Surecn2062622 API manufacturers, exporters, distributors and traders.
click here to find a list of Surecn2062622 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Surecn2062622 DMF (Drug Master File) is a document detailing the whole manufacturing process of Surecn2062622 active pharmaceutical ingredient (API) in detail. Different forms of Surecn2062622 DMFs exist exist since differing nations have different regulations, such as Surecn2062622 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Surecn2062622 DMF submitted to regulatory agencies in the US is known as a USDMF. Surecn2062622 USDMF includes data on Surecn2062622's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Surecn2062622 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Surecn2062622 suppliers with USDMF on PharmaCompass.
Surecn2062622 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Surecn2062622 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Surecn2062622 GMP manufacturer or Surecn2062622 GMP API supplier for your needs.
A Surecn2062622 CoA (Certificate of Analysis) is a formal document that attests to Surecn2062622's compliance with Surecn2062622 specifications and serves as a tool for batch-level quality control.
Surecn2062622 CoA mostly includes findings from lab analyses of a specific batch. For each Surecn2062622 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Surecn2062622 may be tested according to a variety of international standards, such as European Pharmacopoeia (Surecn2062622 EP), Surecn2062622 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Surecn2062622 USP).
LOOKING FOR A SUPPLIER?